Related Experiment Video
Updated: Aug 9, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Pattern of multiple myeloma in Kenyans
1University of Nairobi, Department of Medicine, Kenyatta National Hospital and Medical School.
This study on myeloma in Kenyan Africans found common diagnostic signs like anemia and bone lesions. Poor prognosis was linked to low albumin and high urea levels.
Area of Science:
- Hematology
- Oncology
- Epidemiology
Background:
- Multiple myeloma is a hematologic malignancy affecting plasma cells.
- Previous literature suggested myeloma was infrequent in indigenous African populations.
- Understanding the disease's presentation and prognosis in diverse populations is crucial.
Purpose of the Study:
- To describe the clinical characteristics and diagnostic findings of multiple myeloma in Kenyan Africans.
- To assess the frequency of myeloma in this population.
- To identify factors associated with a poor prognosis.
Main Methods:
- Retrospective analysis of 75 myeloma patients diagnosed at Kenyatta National Hospital, Nairobi.
- Data collected included demographics, clinical symptoms, radiological findings (X-ray skeletal survey), and laboratory results (ESR, albumin, urea, creatinine, etc.).
- Statistical analysis was performed to determine associations between clinical factors and prognosis.
Main Results:
- The study included 75 patients with a male to female ratio of 1.7:1 and a mean age of 51.5 years.
- Common presenting features included anemia (81.3%), osteolytic lesions (80%), bone pain (66.7%), and elevated ESR (77.3%).
- Significant findings associated with poor prognosis (p<0.05) were hypoalbuminemia, elevated blood urea, hyperuricemia, and elevated serum creatinine.
Conclusions:
- Multiple myeloma is not infrequent in indigenous Kenyan Africans.
- The clinical presentation shares similarities with other populations, with a characteristic diagnostic tetrad.
- Hypoalbuminemia and renal impairment are significant indicators of poor prognosis in this cohort.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:53Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022